dc.contributorUniversidade de São Paulo (USP)
dc.contributorUniversity from Ribeirão Preto
dc.contributorUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2014-05-27T11:30:33Z
dc.date.available2014-05-27T11:30:33Z
dc.date.created2014-05-27T11:30:33Z
dc.date.issued2013-09-01
dc.identifierJournal of Pharmacy and Pharmacology, v. 65, n. 9, p. 1337-1346, 2013.
dc.identifier0022-3573
dc.identifier2042-7158
dc.identifierhttp://hdl.handle.net/11449/76448
dc.identifier10.1111/jphp.12105
dc.identifierWOS:000322869700007
dc.identifier2-s2.0-84881481501
dc.identifier2224433126054725
dc.description.abstractObjectives Our main objectives were to investigate the affinity properties of endothelial and muscular α1D-adrenoceptors and to characterize the cross-talk between endothelial α1D- adrenoceptors and β2-adrenoceptors in rat carotid. Methods Relaxation and contraction concentration-response curves for phenylephrine (α1-adrenergic agonist) were obtained in carotid rings in absence or presence of increasing concentrations of BMY7378 (α 1D-adrenergic antagonist), combined or not with increasing concentration of ICI-118,551 (β2-adrenergic antagonist). Schild analysis was used to estimate the affinity constant from pA2 values of BMY7378. Key Findings BMY7378 produced an unsurmountable antagonism on phenylephrine-induced relaxation but a surmountable antagonism on phenylephrine-induced contraction. BMY7378 potency was higher in inhibiting the relaxation than the contraction induced by phenylephrine because the rightward shifts induced by BMY7378 were greater in the relaxation. The apparent pA 2 value for BMY7378 in phenylephrine-induced relaxation was greater than in contraction. When combined with ICI-118,551, BMY7378 yielded a surmountable antagonism on phenylephrine-induced relaxation and presented a pA2 value similar to that obtained in phenylephrine-induced contraction. Conclusions Endothelial α1D-adrenoceptors, which mediates rat carotid relaxation, present high ligand affinity because of the cross-talk with β2-adrenoceptors, which explains the higher potency of phenylephrine in inducing relaxation than contraction and the atypical unsurmountable antagonism produced by BMY7378 on phenylephrine-induced relaxation. © 2013 Royal Pharmaceutical Society.
dc.languageeng
dc.relationJournal of Pharmacy and Pharmacology
dc.relation2.309
dc.relation0,657
dc.rightsAcesso restrito
dc.sourceScopus
dc.subjectmolecular and clinical pharmacology
dc.subjectmolecular and receptor pharmacology
dc.subjectother topics
dc.subjecttissue and cellular pharmacology
dc.subject3 isopropylamino 1 (7 methyl 4 indanyloxy) 2 butanol
dc.subject8 [2 [4 (2 methoxyphenyl) 1 piperazinyl]ethyl] 8 azaspiro[4.5]decane 7,9 dione
dc.subjectalpha 1D adrenergic receptor
dc.subjectbeta 2 adrenergic receptor
dc.subjectcyclic AMP
dc.subjectnitric oxide
dc.subjectphenylephrine
dc.subjectpotassium channel
dc.subjectanimal cell
dc.subjectanimal tissue
dc.subjectartery constriction
dc.subjectbinding affinity
dc.subjectcarotid artery
dc.subjectcontrolled study
dc.subjectcoronary artery dilatation
dc.subjectendothelium cell
dc.subjectgap junction
dc.subjectmale
dc.subjectmuscle cell
dc.subjectnonhuman
dc.subjectrat
dc.subjectsignal transduction
dc.titleCross-talk with β2-adrenoceptors enhances ligand affinity properties from endothelial alpha1D-adrenoceptors that mediates carotid relaxation
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución